News

Home therapy with enzyme replacement therapy for Gaucher disease: a short statement from the European Working Group on Gaucher Disease (EWGGD)

30 July 2020

Statement on Home Therapy

Home therapy with enzyme replacement therapy for Gaucher disease: a short statement from the European Working Group on Gaucher Disease (EWGGD)

Since the availability of enzyme replacement therapy for Gaucher disease …

read more »

IGD Home Therapy Photo Competition

22 July 2020

#IGD2020 will focus on home therapy and our campaign will be totally online with no printed materials or merchandise.

We will be producing an online poster which can be shared on social media to promote the day and to raise awareness and would …

read more »

AVROBIO Announces New Patients Dosed in Gaucher Disease and Cystinosis Clinical Trials

6 July 2020

AVROBIO has announced that the first patient has been dosed in their Phase 1/2 GuardOne trial of AVR-RD-02, AVROBIO’s investigational gene therapy for Gaucher disease type 1.

Our CEO Tanya Collin-Histed says "This is exciting news for …

read more »

Orphazyme phase 2 study of arimoclomol in Gaucher disease

24 June 2020

Sharing news from Orphazyme A/S, our CEO Tanya Collin-Histed writes:

“The news is a step forward for Gaucher disease patients and their families. We are excited to hear that there was evidence of arimoclomol’s ability to cross the …

read more »

IGA and CENTOGENE Team Up to Ensure myLSDapp Provides the Highest Level of Patient Data Protection

15 June 2020

The International Gaucher Alliance (IGA) has teamed up with CENTOGENE to review the data protection measures of myLSDapp. The collaboration not only ensured high levels of security, but led to further adaptations of the patient consent forms related …

read more »

Minutes from IGA's Biennial General Meeting

29 May 2020

A note from our Chair:

Thank you to all those who attended the IGA’s Biennial General Meeting on the 23rd of May, 2020. It was our pleasure to see all of you virtually and we appreciate that you ​decided to spend Saturday …

read more »

COVID-19: IGA and European GD Network Gaucher Research Survey

29 May 2020

Calling all Gaucher patients

We would like to ask you to complete the following patient survey to help us understand the impact of the disease on Gaucher patients, their families and supporters and to provide invaluable research data with the …

read more »

The IGA initiates a global discussion on home therapy for Gaucher patients

14 May 2020

A Zoom meeting was held for our members on Friday 1 May to share best practice regarding home therapy, hosted by Fernanda Torquati and Kate Theochari who have both been active in their home countries of Italy and Greece respectively in lobbying …

read more »

AVROBIO to Collaborate with Saladax Biomedical

12 May 2020

AVROBIO has announced a partnership with Saladax Biomedical to develop a new blood test that will simplify and streamline therapeutic drug monitoring (TDM) during the conditioning phase of the lentiviral gene therapy process.

Full details can be …

read more »

COVID19 & home treatment

28 April 2020

The International Gaucher Alliance is an umbrella organization with more than 50 members all around the world. The IGA represents the interests of the Gaucher Community.  

Gaucher disease is a rare disease with an incidence of about 1 in …

read more »